Diltiazem Hci Injection, Powder, Lyophilized, For Solution
Product Images NDC 51662-1457

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Diltiazem Hci (NDC 51662-1457). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage (Dosage)

Two tables showing administration data for Diltiazem Hydrochloride Injection. The tables list diluent volumes (100, 250, 500 mL) with corresponding quantities of diltiazem hydrochloride injection, final concentrations (mg/mL), and administration details including dose rates (5-15 mg/h) and infusion rates (10-33 mL/h). A footnote mentions 5 mg/h may be appropriate for some patients.*

FDA Label Image

How Supplied 1 (How Supplied 1)

Table presenting unit of sale, concentration, and individual container details for a drug product. It lists two package options: cartons each containing 10 single-dose fliptop vials with concentrations of 25 mg/5 mL (5 mg/mL) and 50 mg/10 mL (5 mg/mL), and corresponding single-dose fliptop vials available in 5 mL and 10 mL sizes respectively.*

FDA Label Image

How Supplied 2 (How Supplied 2)

A data table listing unit of sale, size, and individual vial information for DILTIAZEM HCI 100 mg. The table includes NDC numbers for a tray containing 10 ADD-Vantage vials and for each 100 mg ADD-Vantage vial.*

FDA Label Image

Figure 1 And 2 (Inst 1)

An instructional illustration showing two steps to open a medication vial. Fig. 1 depicts a hand pressing down on a safety cap on a vial, while Fig. 2 shows the cap being lifted off the vial. This likely demonstrates how to remove the protective seal from a vial before use.*

FDA Label Image

Figure 3 And 4 (Inst 2)

An instructional illustration showing two steps for handling a medical solution bag. Figure 3 depicts a hand lifting or removing the cap from the top of the bag, while Figure 4 shows another hand securing or twisting the cap back on. The bag has two ports at the bottom and is likely prepared for intravenous administration.*

FDA Label Image

Figure 5 And 6 (Inst 3)

Instructional diagrams showing hands manipulating a dialysis or infusion bag with tubing. Fig. 5 depicts a hand pressing a port area of the bag. Fig. 6 shows a hand inserting or securing a connector or cap into the port on the bag. These images illustrate steps in preparing or handling intravenous solution bags.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Vial Labeling (Serialized Labeling)

A vial label for Diltiazem HCl injection, powder, lyophilized for solution, 100 mg strength. The vial is described as a single-dose ADD-Vantage vial for continuous intravenous infusion, not for bolus. The label displays the name Diltiazem HCl prominently in blue with dosage strength and indicates the drug is distributed by HF Acquisition Co., LLC, Mukilteo, WA. A barcode and various product codes are also visible on the label.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Diltiazem Hydrochloride (DILTIAZEM HCI), showing its molecular framework with benzene rings and functional groups including methoxy, acetoxy, and hydrochloride components.*

FDA Label Image

Label Opt. 1 (Vial Label Opt 1)

Label for Diltiazem HCl for Injection sterile powder vial, single-dose ADD-Vantage. The label indicates a strength equivalent to 100 mg Diltiazem HCl per vial. It is intended for continuous intravenous infusion, not for bolus. Storage instructions and manufacturer Hospira, Inc. are included. NDC 0409-4350-13 is printed on the label.*

FDA Label Image

Vial Label Opt. 2 (Vial Label Opt. 2)

Label for DILTIAZEM HCI for Injection, sterile powder equivalent to 100 mg diltiazem HCI, lyophilized for intravenous infusion use. The label states it is a single-use vial and provides storage instructions, manufacturer Hospira, Inc., and cautions against freezing. The NDC on this label is 0409-4350-03.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.